ADAG Stock Summary and Trading Ideas (Adagene - Ads Each Representing 1.25 | NASDAQ:ADAG)

Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.

Adagene - Ads Each Representing 1.25 trades on the NASDAQ stock market under the symbol ADAG.

As of March 27, 2023, ADAG stock price climbed to $1.51 with 12,068 million shares trading.

ADAG has a beta of 0.46, meaning it tends to be less sensitive to market movements. ADAG has a correlation of 0.02 to the broad based SPY ETF.

ADAG has a market cap of $66.13 million. This is considered a Micro Cap stock.

ADAG stock has underperformed the market in the last year with a return of -65.1%, while SPY returned -10.5%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in ADAG shares. However, ADAG has outperformed the market in the last 3 month and 2 week periods, returning +19.8% and +11.9%, while SPY returned +4.0% and +3.2%, respectively. This indicates ADAG has been having a stronger performance recently.

ADAG support price is $1.39 and resistance is $1.61 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ADAG stock will trade within this expected range on the day.